ghk-cu 1mg Peptide GLOW (GHK-Cu / BPC-157 /
Description
Obese Zucker rats treated with AOD-9604 at 500 mcg/kg/day for 19 days showed a statistically significant reduction in body fat compared to vehicle-treated controls
Further testing beyond simple urinalysis to exclude the presence of heme is typically unnecessary
It is possible to feel tenderness, swelling, or bruising near the injection site
It is worth noting upfront that no specific receptor for BPC-157 has been conclusively identified to date
